Curiosity CURI Rallies 186 as Bulls Target 315 20260514 abrdn HQH Stock Slides 123 Support at 1870 20260518 Cerebras IPO Prices Above Expected Range as AI Chipmaker Taps Into Surging Market Demand Trump Returns to X with Attack on Rep Thomas Massie Ahead of Kentucky Primaries Marc Jacobs Departs LVMH After Nearly Three Decades Remains Creative Director as Brand Changes Hands Authentic Brands Group CEO Change Fuels IPO Speculation UK Services Sector Faces Sharpest Decline in a Decade Amid Political and Geopolitical Turmoil ZenaTech ZENA Q4 2025 Results Disappoint What Investors Should Know JM Smucker Faces Analyst Adjustments as JPMorgan Lowers Price Target Genpact CEO Says AI Could Reduce IT Workload and Jobs Requiring Higher Skill Sets Oils Supply Crunch May Arrive Later Than Expected Key Factors Charter Communications Revises Offer Secures Buyout Agreement for Liberty Broadband Aequs Reports 33 Revenue Surge in FY26 Net Loss Widens Amid Consumer Electronics Expansion Australian Lithium Miner Expands Operations Amid Rising Prices VUZI Q1 2026 Earnings EPS Beat and Narrowed Loss Boost Investor Sentiment Cineverse Q1 2026 Earnings SmallerThanExpected Loss as EPS Beats Estimates MSGE Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Halozyme Therapeutics Q1 2026 Earnings EPS Beat Drives Modest Positive Surprise Despite Flat Revenue Disclosure Kodiak AI Inc KDK Q1 2026 Earnings Surprise Profit Beats Expectations Amid Revenue Disclosures Fervo Energy IPO Faces Early Headwinds as AI Infrastructure Stocks Test Market Patience Automated Garment Manufacturing Could Reshape Global Supply Chains Samsung Shares Jump Nearly 8 After Strike Averted Executive Bonuses Spark Governance Debate Berkshire Hathaway Revamps Portfolio with Major Stakes in Delta Air Lines and Alphabet IMF Reprimand Highlights UKs Unaddressed Welfare Bill The Pension Triple Lock Under Scrutiny Jim Cramers Investing Club Morning Meeting Highlights Potential Upside and Market Calls Microns Surge Propels Tech Rally US Stocks Reach New Milestones ADMA Biologics Q1 2026 Earnings EPS Miss Weighs on Shares as Profitability Path Remains in Focus